Profile

NAME Yang Beibei

BIRTH February 2, 1959
Shanghai, PR. China

PRESENT Professor of Otolaryngology
POSITION Chairman, Division of Otolaryngology
(1998 to present)
Zhejiang University Medical School
Hangzhou, 310009

ACADEMIC Zhejiang University Medical School
BACKGROUND (1978-1983) for Bachelor’s degree of medicine
Zhejiang University Medical School
(1984-1987) Graduated research for Master’s degree of medicine
University of Kiel, Germany
(1990-1993) M.D., Magna Cum Laude

PROFESSIONAL Internship(1982-1983), Second Hospital of Jiaxing, Zhejiang
EXPERIENCE Resident, Otolaryngology
Second Affiliated Hospital of Zhejiang University Medical School, Hangzhou (1987-1994)
Assistant Professor of Otolaryngology
Second Affiliated Hospital of Zhejiang University Medical School, Hangzhou (1995-2000)
Professor of Otolaryngology
Second Affiliated Hospital of Zhejiang University Medical School, Hangzhou (2001 to present)

HONORS Scientific Research Award of Zhejiang Province, 2001
Scientific Research Award of Medicine, 2000

STATE AND Division of Otolaryngology, Zhejiang Medical Association
COUNTY Chairman (2000 to present)
COMMITTEES Zhejiang Anticancer Society
Committee (2002 to present)

RESEARCH SUPPORT
1. Scientific Bureau of Zhejiang Province - The Study of Mutant EGFR as Therapeutic Target of Laryngeal Carcinoma (2003-2005)
2. Medical Bureau of Zhejiang Province – The HPV-like Particle’s Infection of Human Mucosa in Vitro. (1999-2001)
3. Foundation for Natural Science of Zhejiang Province – EGFR Expression in the Tissues of Laryngeal Carcinoma (1995 -1996)

4. Medical Bureau of Zhejiang Province – The Research of Recurrent Laryngeal Carcinoma (1994-1995)


MAJOR PUBLICATIONS FOR RECENT 5 YEARS
1.Quantitative analysis of TGF-αand EGFR mRNA in laryngeal carcinoma tissues Chinese Medical Journal 1999;112(12):1088-1092
2.Microscopic examination and measurement of the surgical margin of laryngeal carcinoma. Zhong Hua Zhong Liu Za Zhi 2001;23(2):151-153
3.The serous level of s ICAM associated with clinical staging of laryngeal carcinoma Zhejiang University Journal 2000;29(4):154-156
4.A case report of malignant neurofibroma in parapharyngeal space Zhong Hua Er Bi Yan Hou Ke Za Zhi 2002；37（4）290
5.A case report of large hemangioma of adult larynx Er Bi Yan Hou-Tou Jing Wai Ke 2003；10（4）：255-256
6.The Clinical Value of Quantitative Analysis of Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Zhong Hua Er Bi Yan Hou Ke Za Zhi 2004；39（3）162-165.
7.Effects of Telomerase Activity on Carcinogenesis and Survival in Laryngeal Carcinoma. The Journal International Medical Research 2008; 36:336~342.
8.Yang BB, Jiang H, Chang HY. Malignant triton tumour of the parapharyngeal space: a case arising from the cervical sympathetic nerve. J Laryngol Otol. 2008,122(5):531-4.
9.Beibei Yang, Jia Chen, Xing Zhang, Jiang Cao. Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissues. Auris Nasus Larynx, 2009；36：682-687.
10.Beibei Yang, Hua Jiang, Jia Chen, et al. Dentritic Cells Pulsed With GST–EGFR Fusion Protein：Effect in Antitumor Immunity Against Head And Neck Squamous Cell Carcinoma. Head and Neck. 2009; （Epub ahead of print）.
11.Jiang H, Yang BB. p53, epidermal growth factor receptor and proliferating cell nuclear antigen in laryngeal squamous cell carcinoma are not predictive markers for the effect of adjuvant radiotherapy. Acta Otolaryngol. 2009, 129(1):101-7.

ON RESEARCHING PROGRAM
1.Provincial Department of Public Health "Study on adenovirus-mediated gene therapy by activated caspase-3 controlled by tissue specific promoter in laryngeal carcinoma"

2.Provincial Department of Public Health "Immunotherapy by dentritic cells pulsed with EGFR Fusion in head and neck squamous cell carcinoma"